The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2023 | The evolution of minimally invasive cancer surgery
Magnus Nilsson, MD, PhD, FACS, Karolinska University Hospital in Stockholm, Sweden, discusses the rapid evolution of minimally invasive surgical techniques since the mid-1980s. Over the past 20 years, these techniques have been adopted in cancer surgery, leading to significant changes. Minimally invasive approaches contribute to quicker patient recovery, minimizing the impact on functional recovery and improving the overall quality of life in a shorter period. Research also suggests that complications from surgery may be less severe, and there’s emerging evidence indicating potential long-term survival benefits, possibly attributed to the reduced impact on performance status and the immune system compared to more traumatic open procedures. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.
These works are owned by Magdalen Medical Publishing, protected by global copyright laws. All rights are reserved.
